Bone marrow mesenchymal stromal cells remain of recipient origin after allogeneic SCT and do not harbor the JAK2V617F mutation in patients with myelofibrosis

Author： Bacher Ulrike   Asenova Svetlana   Badbaran Anita   Zander Axel   Alchalby Haefaa   Fehse Boris   Kröger Nicolaus   Lange Claudia   Ayuk Francis  

Publisher： Springer Publishing Company

ISSN： 1591-8890

Source： Clinical and Experimental Medicine, Vol.10, Iss.3, 2010-09, pp. : 205-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Evaluation of JAK2V617F in B and T Cell Neoplasms: Identification of JAK2V617F Mutation of Undetermined Significance (JMUS) in the Bone Marrow of Three Individuals

By  

Acta Haematologica, Vol. 118, Iss. 4, 2007-11 ,pp. : 209-214

Karger

Access to resources Recommend Favorite

Wild-Type JAK2 Secondary Acute Erythroleukemia Developing after JAK2-V617F-Mutated Primary Myelofibrosis

By  

Acta Haematologica, Vol. 122, Iss. 1, 2009-08 ,pp. : 36-38

Karger

Access to resources Recommend Favorite

No Evidence for JAK2V617F Mutation in Monoclonal B Cells in 2 Patients with Polycythaemia Vera and Concurrent Monoclonal B Cell Disorder

By  

Acta Haematologica, Vol. 128, Iss. 3, 2012-08 ,pp. : 183-186

Karger

Access to resources Recommend Favorite

Leukocytosis, JAK2V617F Mutation, and Hemostasis in Myeloproliferative Disorders

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 36, Iss. 3-4, 2009-01 ,pp. : 148-159

Karger

Access to resources Recommend Favorite

Is the JAK2 V617F Mutation a Hallmark for Different Forms of Thrombosis?

By  

Acta Haematologica, Vol. 124, Iss. 1, 2010-07 ,pp. : 49-56

Karger

Access to resources Recommend Favorite